![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 40, 28063-28066, October 1, 1999
From the Department of Biochemistry and Molecular Biophysics,
Washington University School of Medicine,
St. Louis, Missouri 63110
Serine proteases of the chymotrypsin family have
maintained a common fold over an evolutionary span of more than one
billion years. Notwithstanding modest changes in sequence, this class of enzymes has developed a wide variety of substrate specificities and
important biological functions. Remarkably, the C-terminal portion of
the sequence in the protease domain accounts fully for this functional
diversity. This portion is often encoded by a single exon and contains
most of the residues forming the contact surface in the active site for
the P1-P3 residues of the substrate, as well as domains responsible
for the modulation of catalytic activity. The evolution of serine
proteases was therefore driven by optimization of contacts made with
the unprimed subsites of the substrate and targeted a relatively short
portion of the sequence toward the C-terminal end. The dominant role of
the C-terminal sequence should facilitate the identification of
function in newly discovered genes belonging to this class of enzymes.
Serine proteases of the chymotrypsin family feature a gamut of
important physiological functions, ranging from digestive and degradative processes to blood clotting, cellular and humoral immunity,
fibrinolysis, fertilization, and embryonic development (1). How this
variety of functions emerged during evolution from a highly conserved
three-dimensional fold (2) is incompletely understood. Enzymes involved
in digestive and degradative processes, such as trypsin and
chymotrypsin, are found from bacteria to human and are composed of a
protease domain containing all epitopes for ligand recognition (3, 4).
On the other hand, enzymes involved in more specialized functions such
as blood coagulation, humoral immunity, and fibrinolysis are present
almost exclusively in vertebrates and carry additional modules that
confer more stringent specificity and localize the proteolytic function
in space (5-7). A large repertoire of functions can be created by
linking the protease domain to specialized functional modules, and most
likely this strategy enabled the evolution of highly selective and
specialized enzymes from primitive digestive proteases (8).
The mosaic organization of the primary structure of many serine
proteases has fostered the notion that the protease domain alone would
not bear reliable signatures of function. Previous sequence analyses
and functional characterizations of serine proteases have relied
heavily on the architecture of non-protease domains (6, 8, 9).
Evolutionary trees for the hepatocyte growth factor
(HGF),1 HGF activator,
kallikreins, mast cell protease, and complement lineages have been
constructed in this manner (7, 10-13). However, Doolittle and Feng (5)
were able to construct a reasonable evolutionary tree for clotting and
fibrinolytic proteases from analysis of the protease domain only. This
domain is the only structural component present in all members of the
serine protease family. We therefore posed the question as to whether
this domain would suffice to gain a predictive understanding of the
function of the protease.
Data Base--
Amino acid and nucleotide sequences of 251 chymotrypsin-like serine proteases and homologous proteins were culled
from GenBankTM. Of the 251 original sequences, 89 were
selected for the construction of evolutionary trees to minimize
duplication of nearly identical sequences of the same proteins. Serine
protease domains were aligned from residues 16 to 245 of the
chymotrypsin catalytic domain. Alignments were performed with CLUSTAL_W
(14). Protein distance matrices were calculated using PROTDIST from the
PHYLIP package (15). Unrooted evolutionary trees were constructed using
the Fitch-Margoliash method (16) with the PHYLIP program FITCH.
Analysis of Crystal Structures--
The contribution of
50-residue-long stretches to the surface contacting the substrate in
the active site was calculated for thrombin (1PPB) (17), chymotrypsin
(4CHA) (18), trypsin (1TLD) (19), tissue plasminogen activator (1RTF)
(20), elastase (3EST) (21), and kallikrein A (2PKA) (22). The surface
was calculated using the structure of thrombin inhibited with
H-D-Phe-Pro-Arg-CH2Cl (PPACK) at the active
site as reference. The three residues of PPACK occupy the S3, S2, and
S1 pockets, respectively. The surface area contacting the substrate was
defined as being contributed by any residue within 4.5 Å of PPACK.
Notably, the residues defining this area in thrombin were also found to
define the same area in the other five proteases analyzed and enabled a
consistent comparison of all structures. The area contacting the
substrate was calculated for 50-residue-long stretches along the
sequence, using the chymotrypsin(ogen) numbering and excluding all
insertions relative to chymotrypsin. These insertions contributed no
more than 5% to the S1-S3 pockets.
Analysis of nearly 90 non-redundant sequences of the protease
domain, corresponding to residues 16-245 in the bovine
chymotrypsin(ogen) numbering, was carried out using the
Fitch-Margoliash algorithm (16) and gives the tree depicted in Fig.
1. The separation of functions is
immediately recognizable in the tree, with the digestive and
fibrinolytic proteases segregated from the complement and blood-clotting enzymes. The separation and the results derived from it
are entirely independent of how the tree is rooted. We therefore chose
the oldest eucaryotic organism as origin. With this choice, there is
early divergence of several of the arthropod enzymes and of enzymes of
cell-mediated immunity from the same ancestral lineage. This concurs
with previous evidence of a unique origin of proteases of cell-mediated
immunity (23). There is also early divergence of HGF-related enzymes
and kallikreins. In contrast, there is late divergence of HGF
activator-related enzymes and blood-clotting enzymes. The latter are
always interspersed with complement enzymes, and both groups diverge in
close relation to late diverging arthropod enzymes, especially
dorsal-ventral determinants from Drosophila melanogaster
(24-26). Additionally, fibrinolytic enzymes show late divergence, in
association with degradative proteases that include digestive
proteases, and branch from the tree at various evolutionary times. The
most striking trends appear to be the previously documented shared
ancestry between complement and blood-clotting enzymes (27), the close relationship between these and arthropod enzymes, and the close association between arthropod enzymes and the proteases of
cell-mediated immunity.
Next, we asked whether the entire sequence of the protease domain was
also necessary, other than sufficient, to provide the documented
separation of function. Trees such as the one in Fig. 1 were
constructed from 50-residue-long fragments of the sequence in the
protease domain. The distance from the ideal tree approximated from
that constructed from the complete sequence was computed in each case
(Fig. 2). The minimum limit of sequence
necessary to produce an acceptable tree that maps serine proteases into functional groups as in Fig. 1 varied according to the position along
the sequence. The tree constructed from the C-terminal segment yielded
coherent separation of functional groups, corresponding closely to the
tree constructed from the entire protease domain. The two trees shared
general relationships and branch points between major functional
groups. Farther than 75 residues from the C terminus, using a
50-residue fragment to construct trees, resulted in the breakup of
major functional groups, with the general exception of proteases of
cell-mediated immunity. That such trees represent a less satisfactory
result is indicated by increased deviations between observed distances
in the tree and the expected deviations based on the protein distance
matrix input (Fig. 2). Remarkably, the tree generated from the last 50 residues alone deviated from the complete tree less than a tree
constructed from the first 175 residues of the protease domain. This
makes the last 50 residues necessary, other than sufficient, to
reliably assign function.
COMMUNICATION
The C-terminal Sequence Encodes Function in Serine Proteases*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

View larger version (38K):
[in a new window]
Fig. 1.
Phylogenetic tree of serine proteases
constructed from residues 16-245 in the protease domain. The tree
is rationally, though arbitrarily, rooted so that enzymes from
sea-based arthropods are the root group. However, the choice of the
root group does not change the topographic structure of the tree. The
tree depicts phylogenetic relationships among protease domains.
Although temporal evolution of protease domains is a likely mechanism
behind the tree structure, the tree should not be looked upon as an
attempt to specify the precise sequence or dates of emergence of
particular groups of proteases. Furthermore, the tree does not imply
that the physiologic functions contributing to group names evolved
concurrently with the proteases that participate in those functions
(e.g. the tree does not suggest that the cell-mediated
immune system developed concurrently with arthropod degradative enzymes
but does suggest that the protease domains of the enzymes listed in the
group are most closely related to the protease domains of arthropod
degradative enzymes). Groups are named according to common functions
shared by either a majority or plurality of the entities in a group.
Proteases that differ in function from their corresponding group name
are marked with annotations (see below). Proteases and proteins are
from vertebrates unless a species is indicated. Most proteases or
proteins are from humans or other mammals. Human proteases and proteins
are used wherever possible. a, factor D is part of the
alternative complement pathway and thus the humoral immune system.
b, batroxobin and ancrod cleave fibrinopeptides and thus act
in fibrinolytic roles. c, plasma kallikrein and factor XI
belong to the coagulation cascade. d, tryptase is a mast
cell protease and participates in the inflammatory response.
e, plasmin is a fibrinolytic enzyme. f,
apolipoprotein A is not a protease but contains a serine protease
domain and participates in atherosclerotic degradation of blood
vessels. g, factor I is part of the alternative complement
pathway and thus the humoral immune system. h, caldecrin is
closely related to elastase but acts to reduce serum calcium levels in
a nonproteolytic way. i, factor XII is a clotting factor
that also has activity similar to hepatocyte growth factor activator
(HGFA). j, serine protease 24D is a digestive
enzyme; its specific function is unknown. k, C. elegans S1 peptidase of unknown function (GenBankTM
accession number 1572759). l, C. elegans S1
peptidase of unknown function (GenBankTM accession number
1326386). m, haptoglobin is not a protease but participates
in humoral immunity as an acute phase protein. n,
trypsin-like enzyme of Streptomyces griseus;
classified with S2a peptidase family. The grouping of this protease
suggests that this enzyme has a eukaryotic origin (2). o,
trypsin-like enzyme of the bread mold Fusarium oxysporum.
p, C. elegans S1 peptidase of unknown function
(GenBankTM accession number 2088818). q,
hypodermins A and B interfere with the cell-mediated immunity of the
host organism (cattle). r, allergens 1 and 2 interfere with
the cell-mediated immunity of the host (cattle). NK, natural
killer; PSA, prostate-specific antigen; SCCE,
stratum corneum chymotryptic enzyme; t-PA, tissue
plasminogen activator; u-PA, urokinase plasminogen
activator; s-PA, salivary plasminogen activator;
MASP, mannose-associated serine protease; CASP,
calcium-activated serine protease.

View larger version (15K):
[in a new window]
Fig. 2.
Sum of squares of deviations
versus position along the chymotrypsin(ogen) sequence
for trees calculated from segments 50 residues in length (
and
interpolating spline; each point maps the center of
the 50-residue-long sequence). Deviations were generated by
comparing the interprotein distances from the tree program and those
specified in the distance matrix, which serves as the input file for
the tree program. Deviations become markedly lower as the C terminus is
approached, indicating that the C-terminal portion of the sequence
specifies a phylogenetic tree that corresponds more closely to the
actual sequence differences (see Fig. 1). Also shown is the
contribution from segments of 50 residues to the solvent-accessible
surface area (Å2) contacting the substrate into the active
site, derived from the crystal structures of chymotrypsin, elastase,
kallikrein, thrombin, tissue plasminogen activator, and trypsin. Each
point represents the average computed from the six
structures, and the dispersion around the point is the
standard deviation of the values. The area increases significantly as
the C-terminal end is approached, mirroring the opposite trend observed
in the deviation from the tree constructed from alignment of the
complete sequence. The horizontal bar at the
top of the figure displays the boundaries of the last exon,
which contains the critical residues in the C-terminal sequence.
The dominant role of the C-terminal sequence in specifying the function
of a serine protease has a direct structural link, insofar as this
portion of the protease domain makes up most of the surface of the
S1-S3 specificity sites that interact with the substrate (Fig. 2). The
contribution to substrate recognition by 50-residue-long stretches of
the sequence was calculated for several enzymes taken from different
branches of the evolutionary tree in Fig. 1. As the C-terminal end is
approached, the surface area contacting the substrate increases sharply
and mirrors the better approximation of the functional grouping
obtained in this region from sequence alignment (Fig. 2). Most of the
residues that guard the entrance to the active site are found in the
C-terminal sequence (Fig. 3). In all
structures analyzed, and regardless of the functional grouping to which
the enzyme belongs, residues 189-220 in the C-terminal sequence were
found to account for >95% of the area around the primary specificity
pocket S1 and the catalytic His57 and >70% of the area
around the specificity sites S2 and S3. These sites contact the three
residues of the substrate immediately upstream from the scissile bond.
Furthermore, the C-terminal end contains the active site
Ser195 (1), the specificity sites S1 and S3 (2), residue
225 that plays a crucial role in the architecture of the S1 site (28), and residues 216 and 226 that control access to the active site and the
primary specificity pocket (29). Previous studies have also
demonstrated that the codon usage for the active site
Ser195 (30) and the nature of residue 225 (31) are
important determinants of sequence-function correlations. The
C-terminal end contains the 220 loop that hosts the Na+
binding site in allosteric proteases (31) and affects the specificity of the enzyme (32). The absolutely conserved C-terminal helix of the
protease domain located in the back of the molecule hosts Trp237 that stabilizes the hairpin loop where the catalytic
Asp102 is situated (2). Finally, two of three absolutely
conserved disulfide bridges in the protease domain connect in the
C-terminal domain (2).
|
The C-terminal sequence of serine proteases contains most of the structural determinants important for direct substrate recognition at the S1-S3 sites. It should be pointed out that residues not contained within the C-terminal domain also shape some of these sites. For example, the S2 and S3 sites of clotting and fibrinolytic proteases are partially shaped by insertions within the 60 loop and residues 99 and 174 (33). However, the overall contribution of the last 50 residues in the sequence to the surface area contacting the bound substrate far exceeds that of any other segment of the structure. In addition, the C-terminal sequence contains domains such as the 220 loop and the C-terminal helix that, although not in direct contact with the bound substrate, nonetheless exert a profound influence on the catalytic activity and specificity of the enzyme. The 220 loop defines most of the water channel embedding the primary specificity pocket (34, 35), and the architecture of this channel, controlled primarily by the nature of residue 225, affects substrate binding up to 5 orders of magnitude (28). In allosteric proteases carrying Tyr225, such as thrombin, related vitamin K-dependent proteases, and some complement enzymes, the binding of Na+ within the water channel endows the enzyme with allosteric properties and enhances substrate recognition (31, 36). Recent findings demonstrate that residues of the 220 loop influence the energetics of substrate binding at each of the S1-S3 sites (37). The C-terminal helix of the protease domain is also a crucial structural determinant that stabilizes the fold of the C-terminal domain of the enzyme and the environment of the catalytic Asp102 (2). Changes in the C-terminal helix can easily propagate to the hairpin loop hosting Asp102 via the critical residue Trp237, thereby affording control and modulation of the catalytic activity of the enzyme.
The foregoing arguments lend support to the hypothesis that the C-terminal segment of the protease domain of serine proteases exerts an overwhelmingly disproportionate influence, compared with other sequence segments, on the recognition of substrate and the control of catalytic activity within the serine protease family. Consequently, the P1-P3 residues of the substrate are expected to dictate binding in a dominant manner, with the primed residues adding to the specificity of recognition to a lesser extent. Mutagenesis data from a number of systems support this conclusion, because mutations in the unprimed sites of the substrate are typically far more deleterious to binding than those involving the primed sites (38).
Consistent with its dominant functional role in substrate recognition, the C-terminal segment of the protease domain of serine proteases seems to have been involved in all of the evolutionary decisions pertaining to this class of enzymes. The exon structure of serine proteases may underlie this phenomenon (39). Chymotrypsin, which possesses the largest number of exons (seven) in the catalytic domain (40), is encoded from Gly193 to the C terminus by one exon that corresponds closely to the boundaries of the 50-residue sequence that produces a coherent functional tree (Fig. 2). Several proteases split this terminal chymotrypsin exon (23, 39), but the location of the intron/exon boundary near Gly193 varies little. Therefore, the C-terminal exon of serine proteases coincides closely with what appears to be the function-determining domain of the protein sequence.
The special role of the C-terminal sequence in serine proteases may
facilitate the identification of function in newly discovered genes,
even when information is available only on limited stretches of the
sequence. The consensus repeat GDSGG around the active site
Ser195 is usually diagnostic of a serine protease. The
results discussed here demonstrate that this sequence and the 30-40
residues immediately downstream from it are both necessary and
sufficient to reliably assign function. We therefore postulate possible
functions for three recently discovered serine proteases from the
nematode worm Caenorhabditis elegans (41). The
protease with GenBankTM accession number 2088818 diverges
just prior to nudel, stubble, and snake in the tree determined from the
16-245 sequence, and with complement and clotting proteases in the
tree derived from the C-terminal 191-245 sequence. We predict that it
has either a developmental or a primordial humoral defense role. The
protease with accession number 1572759 diverges with complement and
clotting proteases in the 16-245 tree and with degradative and
cell-mediated cytotoxic proteases in the 191-245 tree. We therefore
propose that it is a degradative, perhaps cytotoxic enzyme involved in humoral immunity, as nematodes are unlikely to have cell-mediated immune responses. The protease with accession number 1326386 diverges with complement and clotting in both trees and should be involved in
humoral immunity.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Research Grants HL49413 and HL58141.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biophysics, Washington University School of Medicine, Box
8231, St. Louis, MO 63110. Tel.: 314-362-4185; Fax: 314-362-7183;
E-mail: enrico@caesar.wustl.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HGF, hepatocyte growth factor; PPACK, H-D-Phe-Pro-Arg-CH2Cl.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Rawlings, R. D., and Barrett, A. J. (1993) Biochem. J. 290, 205-218 |
| 2. | Lesk, A. M., and Fordham, W. D. (1996) J. Mol. Biol. 258, 501-537[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Rypniewski, W. R.,
Perrakis, A.,
Vorgias, C. E.,
and Wilson, K. S.
(1994)
Protein Eng.
7,
57-64 |
| 4. | Roach, J. C., Wang, K., Gan, L., and Hood, L. (1997) J. Mol. Evol. 45, 640-652[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Doolittle, R. F., and Feng, D. F. (1987) Cold Spring Harbor Symp. Quant. Biol. 52, 869-874[Medline] [Order article via Infotrieve] |
| 6. | Blake, C. C. F., Harlos, K., and Holland, S. K. (1987) Cold Spring Harbor Symp. Quant. Biol. 52, 925-931[Medline] [Order article via Infotrieve] |
| 7. | Farries, T. C., and Atkinson, J. P. (1991) Immunol. Today 12, 295-300[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Patthy, L. (1985) Cell 41, 657-663[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Donate, L. E., Gherardi, E., Srinivasan, N., Sowdhamini, R., Aparicio, S., and Blundell, T. L. (1994) Protein Sci. 3, 2378-2394[Abstract] |
| 10. | Shimomura, T., Miyazawa, K., Komiyama, Y., Hiraoka, H., Naka, D., Morimoto, Y., and Kitamura, N. (1995) Eur. J. Biochem. 229, 257-261[Medline] [Order article via Infotrieve] |
| 11. | Murray, S. R., Chao, J., and Chao, L. (1992) Agents Actions 38 (suppl.), 26-33 |
| 12. | Veloso, D., Shilling, J., Shine, J., Fitch, W. M., and Colman, R. W. (1986) Thromb. Res. 43, 153-160[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Huang, R., and Hellman, L. (1994) Immunogenetics 40, 397-414[Medline] [Order article via Infotrieve] |
| 14. |
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680 |
| 15. | Felsenstein, J. (1995) PHYLIP (phylogeny inference package), version 3.5c, distributed by the author, Department of Genetics, University of Washington, Seattle |
| 16. |
Fitch, W. M.,
and Margoliash, E.
(1967)
Science
155,
279-284 |
| 17. | Bode, W., Turk, D., and Karshikov, A. (1992) Protein Sci. 1, 426-471[Abstract] |
| 18. | Tsukada, H., and Blow, D. M. (1985) J. Mol. Biol. 184, 703-711[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Bartunik, H. D., Summers, L. J., and Bartsch, H. H. (1989) J. Mol. Biol. 210, 813-828[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Lamba, D., Bauer, M., Huber, R., Fischer, S., Rudolph, R., Kohnert, U., and Bode, W. (1996) J. Mol. Biol. 258, 117-135[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Meyer, E., Cole, G., Radhakrishnan, R., and Epp, O. (1998) Acta Crystallogr. Sect. B 44, 26-38[CrossRef] |
| 22. | Bode, W., Chen, Z., Bartels, K., Kutzbach, C., Schmidt-Kastner, G., and Batunik, C. (1983) J. Mol. Biol. 164, 237-282[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Salvesen, G., and Engchild, J. J. (1991) Biomed. Biochim. Acta 50, 665-671[Medline] [Order article via Infotrieve] |
| 24. | Hong, C. C., and Hashimoto, C. (1996) Genetics 143, 1653-1661[Abstract] |
| 25. | Smith, C., Giordano, H., and DeLotto, R. (1994) Genetics 136, 1355-1365[Abstract] |
| 26. |
Appel, L. F.,
Prout, M.,
Abu-Shumays, R.,
Hammonds, A.,
Garbe, J. C.,
Fristrom, D.,
and Fristrom, J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
4937-4941 |
| 27. | Patthy, L. (1990) Semin. Thromb. Hemostasis 16, 245-259[Medline] [Order article via Infotrieve] |
| 28. |
Guinto, E. R.,
Caccia, S.,
Rose, T.,
Fütterer, K.,
Waksman, G.,
and Di Cera, E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1852-1857 |
| 29. |
Perona, J. J.,
and Craik, C. S.
(1997)
J. Biol. Chem.
272,
29987-29990 |
| 30. | Brenner, S. (1988) Nature 334, 528-530[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Dang, Q. D.,
and Di Cera, E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10653-10656 |
| 32. |
Hedstrom, L.,
Szilagyi, L.,
and Rutter, W. J.
(1992)
Science
255,
1249-1253 |
| 33. | Renatus, M., Bode, W., Huber, R., Sturzebecher, J., and Stubbs, M. (1998) J. Med. Chem. 41, 5445-5456[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Krem, M. M., and Di Cera, E. (1998) Proteins 30, 34-42[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Sanschagrin, P. C., and Kuhn, L. A. (1998) Protein Sci. 7, 2054-2064[Abstract] |
| 36. | Di Cera, E., Dang, Q. D., and Ayala, Y. M. (1997) Cell. Mol. Life Sci. 15, 701-730 |
| 37. | Vindigni, A., Dang, Q. D., and Di Cera, E. (1997) Nature Biotechnol. 15, 891-895[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Perona, J. J., and Craik, C. S. (1995) Protein Sci. 4, 337-360[Abstract] |
| 39. | Irwin, D. M., Robertson, K. A., and MacGillivray, R. T. A. (1988) J. Mol. Biol. 200, 31-45[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Bell, G. I.,
Quinto, C.,
Quiroga, M.,
Valenzuela, P.,
Craik, C. S.,
and Rutter, W. J.
(1984)
J. Biol. Chem.
259,
14265-14270 |
| 41. | Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., Coulson, A., Craxton, M., Dear, S., Du, Z., Durbin, R., Favello, A., Fulton, L., Gardner, A., Green, P., Hawkins, T., Hillier, L., Jier, M., Johnston, L., Jones, M., Kershaw, J., Kirsten, J., Laister, N., Latreille, P., Lightning, J., Lloyd, C., McMurray, A., Mortimore, B., O'Callaghan, M., Parsons, J., Percy, C., Rifken, L., Roopra, A., Saunders, D., Shownkeen, R., Smaldon, N., Smith, A., Sonnhammer, E., Staden, R., Sulston, J., Thierry-Mieg, J., Thomas, K., Vaudin, M., Vaughan, K., Waterston, R., Watson, A., Weinstock, L., Wilkinson-Sproat, J., and Wohldman, P. (1994) Nature 368, 32-38[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
F. Marino, Z.-W. Chen, C. E. Ergenekan, L. A. Bush-Pelc, F. S. Mathews, and E. Di Cera Structural Basis of Na+ Activation Mimicry in Murine Thrombin J. Biol. Chem., June 1, 2007; 282(22): 16355 - 16361. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Bush, R. W. Nelson, and E. Di Cera Murine Thrombin Lacks Na+ Activation but Retains High Catalytic Activity J. Biol. Chem., March 17, 2006; 281(11): 7183 - 7188. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ogawa, I. M. Verhamme, M.-F. Sun, P. E. Bock, and D. Gailani Exosite-mediated Substrate Recognition of Factor IX by Factor XIa: THE FACTOR XIa HEAVY CHAIN IS REQUIRED FOR INITIAL RECOGNITION OF FACTOR IX J. Biol. Chem., June 24, 2005; 280(25): 23523 - 23530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Krem and E. Di Cera Conserved Ser residues, the Shutter Region, and Speciation in Serpin Evolution J. Biol. Chem., September 26, 2003; 278(39): 37810 - 37814. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Orcutt, C. Pietropaolo, and S. Krishnaswamy Extended Interactions with Prothrombinase Enforce Affinity and Specificity for Its Macromolecular Substrate J. Biol. Chem., November 22, 2002; 277(48): 46191 - 46196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. C. Rose, K.-S. Ham, A. G. Darvill, and P. Albersheim Molecular Cloning and Characterization of Glucanase Inhibitor Proteins: Coevolution of a Counterdefense Mechanism by Plant Pathogens PLANT CELL, June 1, 2002; 14(6): 1329 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rose and E. Di Cera Substrate Recognition Drives the Evolution of Serine Proteases J. Biol. Chem., May 24, 2002; 277(22): 19243 - 19246. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |